Normal and osteoarthritic human articular cartilage was investigated by in situ hybridization for expression patterns of the fibrillar collagens type I, II, and III to evaluate phenotypic changes of articular chondrocytes related to the disease. In 11 out of 20 samples, a defined subset of chondrocytes in the superficial and upper middle zone of osteoarthritic cartilage showed significant levels of cytoplasmic al (III) mRNA, whereas strong signals of at (II) mRNA were found in the upper and lower middle zone, partially overlapping with the zone of al (III) mRNA-expressing cells. The extent of type II and III collagen expression depended on the integrity of the extracellular matrix surrounding the chondrocytes, and the location within the articular cartilage. No atl (I) mRNA was detectable in osteoarthritic original articular cartilage. The at (I) probe did, however, reveal signals in pannuslike tissue, osteophytes, and bone cells. In normal articular cartilage, no detectable levels of cytoplasmic mRNA for Al (I), a2(I), or al (III) were seen. Using specific mono-and polyclonal antibodies, we found deposition of type III collagen but hardly any of type I collagen in the superficial zone of osteoarthritic cartilage that is consistent with the in situ hybridization results.
Introduction
From studies on cartilage development in vitro and in situ, it has become evident that at least three distinct chondrocyte phenotypes can be distinguished on the basis of the collagen pattern expressed: (a) chondrocyte precursor cells (e.g., limb bud or somite mesenchyme cells synthesizing type I collagen) (1-3); (b) differentiated hyaline chondrocytes (e.g., in embryonal cartilage anlagen, in the resting zone of fetal epiphyseal cartilage, or in articular cartilage expressing collagen types II, IX, Please address correspondence to Dr. K. von der Mark, Max-PlanckSociety, Clinical Research Groups for Rheumatology at the Medical Clinic III, Schwabachanlage 10, 8520 Erlangen, Germany. Receivedfor publication 18 May 1992 and in revisedform 28 August 1992. XI, and VI [for review see references [4] [5] [6] ; and (c) hypertrophic chondrocytes in the growth zone of fetal epiphyseal or rib cartilage, synthesizing predominantly type X collagen (for review see reference 7) . A fourth chondrocyte phenotype resembling the chondrocyte precursor cells can be induced in vitro by culturing and repeated passage of chondrocytes in monolayer, by BUdR, embryo extract, fibronectin, or retinoic acid (for review see reference 8) . This modulation of the collagen expression pattern has been compared with a "dedifferentiation" and involves the transition to a fibroblastic cell shape, the formation of focal contacts and stress fibers, and synthesis oftypes I, III, and V collagen (8) .
While extensive literature is available on the expression of these collagens by articular chondrocytes in vitro and in normal fetal and adult cartilage in vivo (9-1 1 ), relatively little is known on the collagen expression pattern by articular chondrocytes in degenerating cartilage. Several studies describe a stimulation of collagen synthesis as a response to cartilage degradation in experimentally induced osteoarthritic models ( 12, 13) or in human osteoarthritis ( 14) . The newly synthesized collagens seem to be predominantly type II collagen ( 12, 15) as well as type IX, XI, and VI collagen ( 16) . There are, however, also reports on the identification of type I and III collagen in osteoarthritic cartilage by immunohistochemical and biochemical methods (17) (18) (19) , indicating "dedifferentiation" of chondrocytes similar to the above described phenomenon in vitro. These results could not be confirmed by several other biochemical studies, which were not able to detect any type I collagen in osteoarthritic cartilage except in fibrocartilage ( 14, 15) . In a recent study, areas oftype X collagen deposition around chondrocyte clusters in osteoarthritic cartilage was shown indicating chondrocyte hypertrophy (20) .
In this study, we have investigated the cartilage expression of collagen types I, II, and III in chondrocytes of normal and osteoarthritic human cartilage both at protein and mRNA level to check for phenotypic changes in vivo similar to those found in culture systems in vitro. We present evidence for the uncoupling of coordinated collagen expression pattern consisting either of types II, IX, and XI in differentiated, or of types I, III, and V in "dedifferentiated" chondrocytes, and describe subsets of chondrocytes expressing types II and III, but not type I collagen.
Methods
Tissue preparation and histochemistry. Histological sections were prepared from 20 mainly late stage osteoarthritic (knee arthroplasties/hip replacements) and eight normal cartilage specimens. In this study, only samples of original articular cartilage were investigated; osteophytes and other repair cartilage were excluded. Cartilage slices were fixed with 4% paraformaldehyde in PBS for 24 h, dehydrated, embedded in on parallel sections. The latter two were used to estimate the content of proteoglycans (21 ) . All samples were histologically graded according to Mankin (22).
Immunohistochemistry. Deparaffinized sections were decalcified with 0.3 M EDTA (pH 7.2) and incubated with testicular hyaluronidase (2 mg/ml, PBS, pH 5, 30 min at room temperature). For the detection of type II collagen in normal and osteoarthritic samples, pretreatment with pronase (1 mg/ml, PBS, pH 7.3, 30 min at room temperature) was necessary. The staining pattern obtained with antibodies to type I collagen or pN-a(III) was independent from section pretreatments with pronase. Primary antibodies were incubated for 1 h and visualized using alkaline-phosphatase-labeled secondary antibodies and 3-hydroxy-2-naphtylacid 2,4-dimethylanilid as color substrate. Nuclei were counterstained with hematoxylin. As negative control, the primary antibody was replaced either by preimmune serum or Trisbuffered saline (pH 7.2).
A monoclonal antibody (CII D33) directed against an epitope in the CB 10 fragment of type II collagen was kindly provided by Dr. R. Holmdahl (University of Uppsala, Sweden) (23) . Rabbit antisera against human type I collagen were purchased from Institut Pasteur (Lyon, France) or prepared and tested as described elsewhere (20).
Polyclonal antibodies against type III procollagen were kindly provided by Dr. Gunzler (Hoechst Co., Frankfurt, FRG). Preparation and specificity of this antibody are described in (24) . Antibodies to the pN-propeptide of type III procollagen were shown to give identical staining patterns as antibodies to type III collagen since the majority of the pN-peptides remain attached to the type III collagen fibrils (25) .
Preparation ofRNA probes. For specific RNA probes, suitable fragments of human collagen chains a I (I), a2(I), a I (II), and a I (III) mRNA were selected and recloned into pGEM vectors (Promega Corp., Madison, WI) (for localization on the genes see Fig. 1 The constructs were linearized and transcribed in vitro using T7 and SP6 RNA-polymerase (both from Promega) to generate antisense and sense transcripts respectively. The probes were labeled with ,uCi (a-35S)-UTP ( 1,200 Ci/mmol, New England Nuclear, Dreireich, FRG) per 0.5-1 gg of template DNA to a specific activity of < 1.2 x 109 cpm/,ug, and nonincorporated nucleotides were separated by alcohol precipitation. The quality of the transcripts was controlled using denaturating formaldehyde agarose gels. Northern blotting experiments using 5 ,ug of total RNAs of human fetal chondrocytes, fibroblasts, and HT 1080 cells grown in monolayer cultures (F12 medium, 10% FCS) were performed to confirm the specificity of the transcripts and to avoid "sticky" probes. Total RNA was extracted using the 4 M guanidine thiocyanate method (30) .
In situ hybridization. In situ hybridization was performed as described in detail elsewhere (31 ) . In brief, deparaffinized and rehydrated sections were digested with proteinase K (20 ug/ml), postfixed, and acetylated in 0.25% acetic anhydride. The sections were hybridized for 12-16 h at 430C with riboprobes at a final activity of 3-6 x 10' cpm/ ml depending on their length. After hybridization, the tissue sections were washed 40°C 2x SSC/0.5% ,-mercaptoethanol, and 40°C 0.5X SSC/0.5% /0-mercaptoethanol, treated with RNAses A (20 Mg/ml) and Ti (50 U/ml), washed again for 2 h 45°C 2x SSC/50% formamide/ 0.5% ,B-mercaptoethanol. After three times in 0.1 X SSC at room temperature, the slides were dehydrated.
Autoradiography was performed (Kodak NTB-2 nuclear track emulsion) for 3-4 d and sections were counterstained in 5% Giemsa dye.
Results

Selection ofRNA probes
Because ofhigh homologies existing between the closely related fibril-forming collagen genes, particular efforts were directed towards careful selection of DNA fragments to rule out crosshybridization effects (32) . This is especially valid for in situ hybridization, where additional control informations such as transcript size, etc., are missing. Therefore, we selected and prepared collagen cDNA probes by the following criteria: ( (Fig. 3 b) . These were confined to layers below the zone showing proteoglycan loss (Fig. 3, b and h ). An example representing middle to late phases ofcartilage degeneration is depicted in Fig. 3, a- (Fig. 3 c; for schematic representation, see Fig. 4 ). In none of the investigated samples was expression of a 1 (III) mRNA found without simultaneous expression of a 1 (11) (Fig. 3, a and i) , in contrast to fibroblastic cells in pannuslike tissue overlaying the articular cartilage in an osteoarthritic femur condyle of a 65-yr-old patient who showed signals with the a (I) and a2(I) probes (Fig. 3 i) .
Pannuslike tissue also showed cytoplasmic a I(III) mRNA (Fig. 3 k) . Chondrocytes of the superficial zone were negative for both a 1 (11) and a 1 (111) in sites of severe depletion of the matrix of proteoglycans. These cells were, however, in all cases viable as shown by in situ hybridization with the 18S rRNA probe (Fig. 3, d and 1 Fig. 3, a-d) . The distribution is consistent with the pattern of type III mRNA expression (Fig. 3, c and k) . Nevertheless, type II collagen remained the most prominent collagen in the interterritorial matrix (Fig. 3 f) resting chondrocytes, or of types I, III, and V collagens described for the "dedifferentiated" or modulated phenotype in vitro (8, 10, 34, 35) . In noncartilagenous tissue, collagen type III is expressed in vivo and in vitro mostly together with collagen type I, though in different ratios (36, 37) . In chondrocyte cultures modulated in vitro, a rather abrupt switch from type II to types I and III collagen synthesis is observed with type I as the most abundant protein synthesized ( 10, 35, 38) , suggesting that both collagens are coregulated. The fact that we cannot detect type I collagen mRNA in osteoarthritic chondrocytes demonstrates that the phenotypic changes of osteoarthritic chondrocytes described in this study is different from the dedifferentiation event ofchondrocytes seen in vitro. Our results are in favor of an uncoupled, individual regulation of single collagen genes in the chondrocyte in situ. This seems also the case for the COLlA 1 and COLIA2 genes. In one sample, we found signals with the a2 (I) probe in chondrocytes of the deep zone of osteoarthritic cartilage in the absence of a I(I) transcripts, while the same al (I) probe revealed strong signals in osteoblasts in the same sample. Since no type I collagen staining could be achieved in the environment of these chondrocytes using a polyclonal antibody, we assume that these "a2 (I)" transcripts may represent the noncollagenous, cartilage-specific transcript of the COL1A2 gene, controlled by a different promotor (39) . To distinguish between both alternative transcripts, probes derived from the differing 5 '-ends will be necessary.
The factors and mechanisms regulating transcription and translation of collagen types in osteoarthritic cartilage are not yet known. Systemic factors like cytokines produced (e.g., from synovial tissue) may affect the collagen expression pattern. For example, interleukin 1 enhances type I and III collagen in human chondrocytes and suppresses the expression of the cartilage-specific collagens in vitro (40) . However, the fact that the alterations in collagen expression pattern in osteoarthritis are not evenly distributed over the articular cartilage, but different in marginal or weight bearing areas, suggest an additional strong impact by the local environment; e.g., the integrity of the extracellular matrix and mechanical factors.
In conclusion, we were able to demonstrate expression and synthesis ofcollagen type III 
